NOVA22007 clinical trials
How each study uses NOVA22007 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- NOVA22007
- 1
Studies by the year they started
3 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 1 |
Who runs them
Industry 2 · Other 1
Santen SAS (2) · Campus Bio-Medico University (1)
Studies
Open first, then newest update. How each study uses NOVA22007 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal KeratoconjunctivitisCompletedPhase 3Santen SASNCT01751126Written as NOVA22007 ''Ciclosporin''
- NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry EyeCompletedPhase 2Santen SASNCT00739349Written as NOVA22007 ''Cyclosporine''
- Cyclosporin A Eye Drop Treatment in Vernal KeratoconjunctivitisCompletedPhase 3Campus Bio-Medico UniversityNCT00426023Written as Cyclosporine A 0,05% eye drop